Covered Companies: Daré Bioscience
Most Recent Event

Closing Bell
July 14, 2026
Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health.
NASDAQ: DARE
About
Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility.
Past Events
What This Means
June 25, 2026
Sabrina Martucci Johnson, President and CEO of Daré Bioscience, discusses tthe upcoming launch of Flora Sync LF5™ and its significance as the company’s first consumer health product and opportunity to generate direct product revenue.
What This Means
March 12, 2026
Sabrina Martucci Johnson, President and CEO of Daré Bioscience, discusses the significance of the FDA’s IND clearance and how this milestone allows Daré to advance DARE-HPV into Phase 2 clinical development in alignment with Daré’s broader strategy to address unmet needs in women’s health.
